Replies to post #69 on Medical Forum

[PoemStone]

ACRX. AcelRx Receives Notice of Eligibility for Centralized Review from European Medicines Agency for the Sufentanil NanoTab® PCA System
Centralized review process used for products that provide a significant therapeutic, scientific or technical innovation to patient health
http://finance.yahoo.com/news/acelrx-receives-notice-eligibility-centralized-113000549.html